Why Copart (CPRT) Stock Is Trading Up Today

Copart (CPRT) stock rose 3.8% after JPMorgan upgraded it to Overweight and raised its price target to $40.00 from $32.00. The shares were trading at $33.37, down 11.7% year-to-date. The company is reportedly among suitors for CCC Intelligent Solutions, though no deal is certain. CPRT is 33.2% below its 52-week high of $49.97.

Original reporting
Published Sep 3, 2026, 4:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 3, 2026, 5:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Copart (CPRT) Stock Is Trading Up Today — source image
Decision brief

The 30-second read

$CPRTBullishHigh
01

Why it matters

The JPMorgan upgrade provides a fresh bullish signal, likely to attract short‑term traders and could lift the stock toward the new $40 target.

02

Market read

Analyst upgrades are a primary driver of intraday price moves; this upgrade sparked a 3.3% rise, indicating immediate trading relevance.

03

What to watch

Potential competitive pressure from other auction platforms and macro‑economic demand for used vehicles.

Relevance 7/10Novelty 8/10Timing: morning session today

Background

Copart is an online vehicle auction company whose stock has been relatively stable with few large moves.

Company-level read

Ticker impact

$CPRTBullishHigh confidence
Context

JPMorgan upgraded Copart to Overweight and raised the price target to $40, driving a 3.3% jump in the morning session.

Expected impact

Expect further short‑term buying pressure, potential 5‑7% gain if momentum holds.

Evidence & confidence

Upgrade is a fresh, primary catalyst; price already rose 3.3% on the news.

Market effects

Auto‑auction and used‑vehicle platforms may see increased analyst attention and short‑term buying.

U.S. market participants focused on the upgrade; limited broader regional effect.

Minimal global impact beyond U.S. investors tracking the sector.

Counterpoint

The upgrade may be premature if underlying earnings growth does not meet the higher target.

Key entities

  • Copart Inc.

    Online vehicle auction platform (NASDAQ: CPRT).

  • JPMorgan Chase & Co.

    Issued the Overweight upgrade and raised price target.

Related articles

$CPRTMed

Why Copart (CPRT) Stock Is Trading Up Today

Copart (CPRT) shares rose 6.1% after Bloomberg reported it is among potential bidders for CCC Intelligent Solutions. The deal, if completed, would expand Copart's insurance claims and repair services. CPRT is down 10.9% YTD, trading 32.7% below its 52-week high.

$CPRTHighAI 9/10

Car-Seller Copart Among Suitors for Car Insurance Software Firm CCC

Copart Inc. is in talks to acquire CCC Intelligent Solutions, a car-insurance software provider. Copart, valued at $29B, competes with private equity firms GTCR and Veritas. CCC shares rose 6.7% to $7.14, while Copart's fell 0.6% to $31.51. CCC's market value is $4.2B, down from $8B in 2023. Activist investor Elliott Management holds a large stake in CCC.

$CPRTHighAI 9/10

Copart Q3 Earnings Call Highlights

Copart reported fiscal Q3 2026 revenue up 2.1% to $1.24B and net income of $402.4M, with diluted EPS up 2.4% to $0.43, according to its earnings call. Insurance unit volumes fell 2.7% globally (4.2% in the U.S.). Management cited higher average selling prices (+4.6%) and gross margin rising 71 bps to 46.3%.

$TSNMed

Stocks making the biggest moves midday: Tesla, Ciena, Meta, Snowflake, Ultragenyx Pharmaceutical & more

Tyson Foods fell 7% after cutting fiscal 2026 guidance. Meta rose 3% on AI model launch. Dell gained 5% post-earnings. Crypto-related stocks climbed with bitcoin. Robinhood jumped 15% on Deutsche Bank's report. Ciena dropped 9% despite beating estimates. Tesla advanced 6% ahead of Cybercab event. Snowflake surged 22% on strong earnings. HPE slipped 4% with lower-than-expected growth forecast. Broadcom lost 3% on weak revenue outlook. Campbell's fell 9% on lagging guidance. Ultragenyx plunged 44%